Investment Thesis
International Stem Cell Corporation exhibits severe financial distress with negative stockholders' equity of -$3.8M, indicating the company is technically insolvent. Despite modest revenue growth of 16.6% YoY to $6.9M, the company burns cash operationally (-$24K OCF) and has negative free cash flow of -$64K, with dangerously low liquidity ratios that threaten near-term viability.
Strengths
- Revenue growth of 16.6% YoY demonstrates demand for core products/services
- Positive operating income of $46K shows some operational profitability before capital structure effects
- Cash position of $966K provides minimal runway for operations
Risks
- Negative stockholders' equity of -$3.8M indicates technical insolvency and existential solvency risk
- Current ratio of 0.80x and quick ratio of 0.46x show severe liquidity crisis with current liabilities exceeding current assets
- Negative free cash flow of -$64K combined with operating cash burn suggests inability to fund operations or growth without capital injection
- Interest coverage ratio of 0.4x indicates inability to service debt obligations from operating earnings
- No insider buying activity in last 90 days suggests lack of confidence from management
Key Metrics to Watch
- Operating cash flow trend and path to cash flow positivity
- Stockholders' equity recovery and balance sheet restructuring
- Revenue sustainability and gross margin realization if disclosed
- Cash runway duration given current burn rate
- Debt restructuring or equity infusion announcements
Financial Metrics
Revenue
6.9M
Net Income
-70.0K
EPS (Diluted)
$-0.01
Free Cash Flow
-64.0K
Total Assets
5.3M
Cash
966.0K
Profitability Ratios
Gross Margin
N/A
Operating Margin
0.7%
Net Margin
-1.0%
ROE
N/A
ROA
-1.3%
FCF Margin
-0.9%
Balance Sheet & Liquidity
Current Ratio
0.80x
Quick Ratio
0.46x
Debt/Equity
N/A
Debt/Assets
90.1%
Interest Coverage
0.40x
Long-term Debt
N/A
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings.
It does not include stock price data and should not be considered financial advice.
All fundamental data is sourced from SEC public domain filings.
Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR |
Analysis Date: 2026-03-29T14:06:10.894991 |
Data as of: 2025-09-30 |
Powered by Claude AI